Skip to main content
. Author manuscript; available in PMC: 2015 Feb 3.
Published in final edited form as: Vaccine. 2013 Dec 14;32(6):693–699. doi: 10.1016/j.vaccine.2013.11.098

Table 4.

Association of Log-Transformed Post HPV Vaccination Titers with Days Between Dose 2 and Dose 3

Variable HPV-6 HPV-11 HPV-16 HPV-18

Coefficient (SE) P-value Coefficient (SE) P-value Coefficient (SE) P-value Coefficient (SE) P-value
Days between Doses 2 & 3 0.002 (0.001) 0.074 0.003 (0.001) <0.001 0.002 (0.001) 0.049 0.002 (0.001) 0.039
Age −0.067 (0.037) 0.072 −0.096 (0.032) 0.003 −0.059 (0.035) 0.095 −0.066 (0.039) 0.087
White (ref: Non-white) 0.108 (0.209) 0.605 −0.155 (0.182) 0.398 0.099 (0.199) 0.621 −0.367 (0.218) 0.095
Body mass index −0.005 (0.014) 0.741 −0.016 (0.013) 0.200 −0.011 (0.014) 0.445 −0.018 (0.015) 0.243
Smoker (ref: non-smoker) −0.205 (0.309) 0.508 −0.134 (0.270) 0.620 −0.411 (0.297) 0.168 −0.754 (0.327) 0.022
Intercept 7.980 (0.919) <0.001 9.123 (0.797) <0.001 9.759 (0.878) <0.001 8.619 (0.964) <0.001

HPV=Human papillomavirus; SE=Standard error; R2= the proportion of variability in the data accounted for by the model. For HPV-6, R2=0.051, for HPV-11, R2=0.184, for HPV-16, R2=0.063, for HPV18, R2=0.102